Related Experiment Video
Updated: Dec 28, 2025

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Intracerebral Hemorrhage Outcomes in the Very Elderly
Rachel Forman1, Katarzyna Slota1, Fawaz Ahmad1
1Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois.
Insights
Outcomes data for elderly intracerebral hemorrhage (ICH) patients are limited. This study found 35% of patients aged 80+ had good outcomes, suggesting age alone shouldn't preclude aggressive treatment for select ICH cases.
Area of Science:
- Neurology
- Geriatrics
- Critical Care Medicine
Background:
- Limited outcomes data exist for patients over 80 years old with intracerebral hemorrhage (ICH).
- Understanding outcomes in this demographic is crucial for clinical decision-making and resource allocation.
Purpose of the Study:
- To describe the outcomes of patients aged 80 and above who presented with primary intracerebral hemorrhage.
- To identify factors associated with favorable or unfavorable outcomes in this elderly population.
Main Methods:
- A retrospective study analyzed data from 220 patients aged 80+ admitted with primary ICH between January 2012 and July 2018.
- Data were sourced from the Rush University Get With The Guidelines database.
- Outcomes were assessed based on discharge disposition and clinical factors like ICH score and hemorrhage location.
Main Results:
- The majority of patients were female (68.2%) with a mean age of 85.6 years.
- Common ICH etiologies included hypertension (51.8%) and cerebral amyloid angiopathy (26.8%).
- A significant proportion (35%) achieved a good outcome, defined as discharge to home or rehabilitation, while 18.2% died and 18.2% went to hospice.
Conclusions:
- Despite advanced age, 35% of intracerebral hemorrhage patients aged 80 and older experienced favorable outcomes.
- Older patients with supratentorial hemorrhages (volume < 30 cc) without intraventricular extension may achieve good outcomes.
- An ICH score of 2 or higher was associated with a six-fold increased risk of unfavorable outcomes.
Background:
There is a paucity of outcomes data in patients over 80 years presenting with intracerebral hemorrhage (ICH). The primary aim of our study is to describe outcomes in this patient population.
Method:
Retrospective study of patients admitted with primary ICH from January 2012 to July 2018. Data were obtained from the Rush University Get With The Guidelines database; only patients 80 or above were included.
Results:
A total of 1713 patients were screened and 220 patients met inclusion criteria. About 68.2% were female and mean age was 85.6 years old. Median ICH score on admission was 2 (IQR 1-3). Location of ICH included: deep (48.2%), lobar (40%), and cerebellum (9.5%). ICH etiologies included hypertensive (51.8%), cerebral amyloid angiopathy (26.8%), coagulopathy (5.9%), and the remaining were undetermined. CT angiograms were performed in 34.5% (n = 76) of patients; of these patients one arteriovenous malformation was identified. Patients underwent the following procedures: external ventricular drains (8.6%), decompression (3.6%), and ventriculoperitoneal shunts (1.8%). Tracheostomy and percutaneous gastrostomy placement were performed in 8.2%. About 4.5% had seizures and 1.5% were treated for status epilepticus. Disposition at hospital discharge included: subacute nursing facility ([SNF] 24.1%), acute rehabilitation (23.2%), hospice (18.2%), death (18.2%), home (11.8%), long-term acute care facility ([LTAC] 3.6%), and unknown (1%). Patients with an ICH score ≥2 on admission had a roughly 6 times higher chance of experiencing an unfavorable outcome (LTAC, SNF, or death), when compared to patients with lower ICH score.
Conclusions:
This study shows that a significant proportion (35%) of ICH patients ≥80 years old have a good outcome, with discharge to home or to rehabilitation. Our data suggest that older patients with ICH presenting with supratentorial hemorrhages (volume < 30 cc) without intraventricular extension can have good outcomes despite their age.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

